INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 43 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $239,000 | -2.4% | 300,000 | 0.0% | 0.00% | – |
| Q3 2020 | $245,000 | -74.7% | 300,000 | -77.0% | 0.00% | – |
| Q2 2020 | $967,000 | -8.7% | 1,304,000 | 0.0% | 0.00% | – |
| Q1 2020 | $1,059,000 | +15.6% | 1,304,000 | +44.2% | 0.00% | – |
| Q4 2019 | $916,000 | +17.9% | 904,000 | 0.0% | 0.00% | – |
| Q3 2019 | $777,000 | +44.2% | 904,000 | +49.7% | 0.00% | – |
| Q2 2019 | $539,000 | -9.4% | 604,000 | 0.0% | 0.00% | – |
| Q1 2019 | $595,000 | +9.2% | 604,000 | +0.7% | 0.00% | – |
| Q4 2018 | $545,000 | -45.9% | 600,000 | -40.0% | 0.00% | – |
| Q3 2018 | $1,008,000 | +21.4% | 1,000,000 | 0.0% | 0.00% | – |
| Q2 2018 | $830,000 | +3.0% | 1,000,000 | 0.0% | 0.00% | – |
| Q1 2018 | $806,000 | -0.5% | 1,000,000 | 0.0% | 0.00% | – |
| Q4 2017 | $810,000 | +3.1% | 1,000,000 | 0.0% | 0.00% | – |
| Q3 2017 | $786,000 | -27.3% | 1,000,000 | -9.1% | 0.00% | – |
| Q2 2017 | $1,081,000 | +5.1% | 1,100,000 | 0.0% | 0.00% | – |
| Q1 2017 | $1,029,000 | +3.7% | 1,100,000 | 0.0% | 0.00% | – |
| Q4 2016 | $992,000 | +153.1% | 1,100,000 | +214.3% | 0.00% | – |
| Q3 2016 | $392,000 | – | 350,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERBACK ASSET MANAGEMENT LLC | 12,851,000 | $12,016,000 | 2.95% |
| Context Capital Management, LLC | 3,000,000 | $2,804,000 | 2.24% |
| Man Investments (CH) AG | 3,000,000 | $2,798,000 | 1.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 42,500,000 | $39,540,000 | 1.52% |
| MACKAY SHIELDS LLC | 17,069,000 | $15,982,000 | 0.73% |
| HIGHFIELDS CAPITAL MANAGEMENT LP | 73,035,000 | $68,425,000 | 0.63% |
| WOLVERINE ASSET MANAGEMENT LLC | 42,307,000 | $39,554,000 | 0.61% |
| LINDEN ADVISORS LP | 14,122,000 | $13,194,000 | 0.49% |
| GLG LLC | 9,100,000 | $8,486,000 | 0.47% |
| Jabre Capital Partners S.A. | 3,400,000 | $3,179,000 | 0.38% |